Iben Louise Gjelstrup
Geen lopende functies
Vermogen: 163 622 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Iben Louise Gjelstrup
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Iben Louise Gjelstrup via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SANOFI | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SAREUM HOLDINGS PLC | Miscellaneous | Director/Board Member | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Director/Board Member | |
| COLUCID PHARMACEUTICALS INC | Biotechnology | Director of Finance/CFO | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Medical Specialties | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GN STORE NORD A/S | Telecommunications Equipment | Investor Relations Contact | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Chief Tech/Sci/R&D Officer | |
| University of Adelaide | College/University | Graduate Degree | |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology GN Hearing A/S develops and sells hearings aids and tools for measuring loss of hearing capability. It provides solutions for all types of ear-related diagnostics and distributes computerized audiology and hearing-instrument fitting equipment. The company was founded in 1957 and is headquartered in Ballerup, Denmark. | Medical Specialties | Director of Finance/CFO | |
| University of Cambridge | College/University | Doctorate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Arcadia University
 Arcadia University Other Consumer ServicesConsumer Services GNP is a premier provider of complex systems manufacturing for the embedded control and communications marketplace. The company designs, manufactures and customizes open system platforms to meet the demanding requirements of its customers' programs, using Commercial off-the-shelf (COTS) technology enhanced by system building blocks of its own design | College/University | Undergraduate Degree | |
| Central Michigan University | College/University | Graduate Degree | |
| Copenhagen Business School | College/University | Masters Business Admin Graduate Degree | |
| University of Tennessee | College/University | Undergraduate Degree | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Human Resources Officer | |
AmerTac, Inc.
 AmerTac, Inc. Electrical ProductsProducer Manufacturing AmerTac, Inc. provides decorative consumer electrical, lighting, lawn and garden products. The company was founded in 1937 and is headquartered in Saddle River, NJ. | Electrical Products | Human Resources Officer | |
ReNeuron Ltd.
 ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Director/Board Member | |
| St. Lawrence University | College/University | Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
| ESSEC Business School | College/University | Masters Business Admin | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Director/Board Member | |
Flash Global Logistics, Inc.
 Flash Global Logistics, Inc. Air Freight/CouriersTransportation Flash Global Logistics, Inc. provides third-party logistics services. It offers mission critical, solutions engineering, flashtrac, flashview and account management. The company was founded in 1983 and is headquartered in Mountain Lakes, NJ. | Air Freight/Couriers | Human Resources Officer | |
| The European Molecular Biology Laboratory | College/University | Corporate Officer/Principal | |
| European Molecular Biology Organization | Corporate Officer/Principal | ||
Park Nicollet Health Services
 Park Nicollet Health Services Hospital/Nursing ManagementHealth Services Park Nicollet Health Services provides healthcare services. It operates Methodist Hospital, Park Nicollet Clinic, the Park Nicollet Foundation, and Park Nicollet Institute. It offers services such as vision correction, cancer treatment, rehabilitation, and plastic surgery. The company is headquartered in St. Louis Park, MN. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Director/Board Member | |
Ossianix, Inc.
 Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Ossianix, Inc. develops single domain antibodies. It develops biotherapeutic products using the versatile single domain VNAR antibody from the shark and also developed highly innovative approaches to target specific cells and tissues such as the brain via the blood brain barrier and peripheral nerve via the neuromuscular junction. The company was founded by Frank S. Walshin, J. Lynn Rutkowski and Corey S. Goodman in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Generic | Chairman | |
| REVO BIOLOGICS INC | Biotechnology | Private Equity Investor | |
| Suffolk University Law School | College/University | Graduate Degree | |
| Nova Nordic A/S | Corporate Officer/Principal | ||
| Dansk Selskab for Flowcytometri | Director/Board Member | ||
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member | |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Igyxos SA
 Igyxos SA Pharmaceuticals: MajorHealth Technology Igyxos SA engages in the development of an innovative medical and pharmaceutical technologies in the field of human fertility. It is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds. The company was founded by Marie-Christine Maurel and is headquartered in Nouzilly, France. | Pharmaceuticals: Major | Chief Executive Officer | |
| The Club Cricket Organisation Ltd. | Director/Board Member | ||
| CESSATECH A/S | Pharmaceuticals: Major | Chief Operating Officer | |
Sumitomo Dainippon Pharma Oncology, Inc.
 Sumitomo Dainippon Pharma Oncology, Inc. BiotechnologyHealth Technology Part of Sumitomo Chemical Co., Ltd., Sumitomo Dainippon Pharma Oncology, Inc. is a developer of novel cancer therapeutics. The private company is based in Cambridge, MA. The company has teams in the US and Japan and is relentlessly committed to advancing purposeful science by transforming new discoveries into meaningful treatments for patients with cancer. Sumitomo Dainippon Pharma Oncology is a wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. The company has a diverse and purposeful pipeline of targeted therapies. The CEO of the company is Patricia S. Andrews. | Biotechnology | Private Equity Investor | |
| Ossianix Uk Ltd. | Director/Board Member | ||
Viewmind, Inc.
 Viewmind, Inc. Information Technology ServicesTechnology Services Viewmind, Inc. is a digital health and artificial intelligence company based in an undisclosed location. The American company provides clinically validated solutions for the early diagnosis of cognitive diseases. Viewmind has developed a unique, reliable, non-invasive, affordable, and accessible digital biomarker technology that delivers clinical results as accurate as today's definitive tests and is viable for early screening at scale. Viewmind's diagnostic solutions analyze eye movement patterns, which is considered cognitive health data in its purest form. The company's tools can unlock cognitive potential and achieve extraordinary mental breakthroughs. Viewmind's comprehensive research delves into the scientific principles behind cognitive enhancement. The company was founded by Matias Shulz, Gerardo Fernandez, and Mark Edwards, with Mark Edwards serving as the CEO since incorporation. | Information Technology Services | Chief Operating Officer | |
Novalgen Ltd.
 Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The private company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 18 |
| Verenigd Koninkrijk | 15 |
| Denemarken | 9 |
| Frankrijk | 6 |
| Duitsland | 3 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 14 |
| Transportation | 3 |
| Miscellaneous | 2 |
| Electronic Technology | 2 |
Operationeel
| Director/Board Member | 50 |
| Corporate Officer/Principal | 22 |
| Independent Dir/Board Member | 15 |
| Chief Tech/Sci/R&D Officer | 13 |
| Undergraduate Degree | 9 |
Sterkste connecties
- Beurs
- Insiders
- Iben Louise Gjelstrup
- Bedrijfsconnecties
